Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irene M Ghobrial

Showing results (1-10 of 332) with videos related to

Pageof 34
Sort By:
Blood|April 27, 2012
Myeloma as a model for the process of metastasis: implications for therapyIrene M Ghobrial
Clinical Advances in Hematology & Oncology : H&O|April 23, 2013
Update on Waldenström's macroglobulinemiaIrene M Ghobrial
Leukemia & Lymphoma|April 2, 2013
Revisiting treatment paradigms in high-risk smoldering multiple myeloma: out with the old, in with the new?Irene M Ghobrial
Hematology. American Society of Hematology. Education Program|December 13, 2012
Are you sure this is Waldenstrom macroglobulinemia?Irene M Ghobrial
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2012
Choice of therapy for patients with Waldenstrom macroglobulinemiaIrene M Ghobrial
Leukemia & Lymphoma|April 26, 2012
Would the real myeloma cell please stand up?Patricia Maiso, Irene M Ghobrial
Clinical Lymphoma, Myeloma & Leukemia|March 16, 2013
The bone marrow microenvironment in Waldenström macroglobulinemiaAmit Agarwal, Irene M Ghobrial
The Journal of Clinical Investigation|November 21, 2018
Autologous graft versus myeloma: it's not a mythShuai Dong, Irene M Ghobrial
Current Cancer Therapy Reviews|February 24, 2015
Biological and Clinical Implications of Clonal Heterogeneity and Clonal Evolution in Multiple MyelomaGiada Bianchi, Irene M Ghobrial
Nature Reviews. Clinical Oncology|January 24, 2025
Early intervention with daratumumab improves survival for patients with high-risk smouldering myelomaOmar Nadeem, Irene M Ghobrial
Pageof 34

Showing results (1-10 of 332) with videos related to

Sort By:
Pageof 34
Blood|April 27, 2012
Myeloma as a model for the process of metastasis: implications for therapyIrene M Ghobrial
Clinical Advances in Hematology & Oncology : H&O|April 23, 2013
Update on Waldenström's macroglobulinemiaIrene M Ghobrial
Leukemia & Lymphoma|April 2, 2013
Revisiting treatment paradigms in high-risk smoldering multiple myeloma: out with the old, in with the new?Irene M Ghobrial
Hematology. American Society of Hematology. Education Program|December 13, 2012
Are you sure this is Waldenstrom macroglobulinemia?Irene M Ghobrial
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2012
Choice of therapy for patients with Waldenstrom macroglobulinemiaIrene M Ghobrial
Leukemia & Lymphoma|April 26, 2012
Would the real myeloma cell please stand up?Patricia Maiso, Irene M Ghobrial
Clinical Lymphoma, Myeloma & Leukemia|March 16, 2013
The bone marrow microenvironment in Waldenström macroglobulinemiaAmit Agarwal, Irene M Ghobrial
The Journal of Clinical Investigation|November 21, 2018
Autologous graft versus myeloma: it's not a mythShuai Dong, Irene M Ghobrial
Current Cancer Therapy Reviews|February 24, 2015
Biological and Clinical Implications of Clonal Heterogeneity and Clonal Evolution in Multiple MyelomaGiada Bianchi, Irene M Ghobrial
Nature Reviews. Clinical Oncology|January 24, 2025
Early intervention with daratumumab improves survival for patients with high-risk smouldering myelomaOmar Nadeem, Irene M Ghobrial
Pageof 34